PACTR201811766698931已完成2 期
The Potential Role of Hydrocortisone in Acute Phosphide Poisoning: A Randamized Clinical Trial
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 19 Year(s) 至 44 Year(s)(—)
- 性别
- All
入选标准
- •Adult patients with severe acute phosphide poisoning manifested by
- •systolic blood pressure (SBP) =80 mmHg
- •pH =7.2, or HCO3 =15 meq/L
排除标准
- •Asymptomatic patients.
- •Patients ingested or exposed to other substances in addition to phosphide.
- •Patients with major medical conditions (e.g. cardiovascular disease, renal or hepatic failure).
- •Patients on steroids therapy.
- •Patients with medical interference by corticosteroid 24 hours before admission.
研究者
相似试验
已完成
不适用
HydroCortisone in Severe Acute PancreatitisDigestive SystemAcute pancreatitisISRCTN53054042Helsinki University Central Hospital (EVO) (Finland)150
招募中
不适用
Effect of Hydrocortisone on Improving Outcome of Pneumatic Reduction of Infantile IntussusceptioDigestive SystemPaediatricsPACTR201602001480323Cairo University Pediatric Surgery Dept80
进行中(未招募)
1 期
Pharmacocinétique de l’Hydrocortisone chez le patient ADdisonien : évaluation de la valeur prédictive de l’ACTH plasmatique pour la titration du traitement substitutif - PHADMedDRA version: 9.1Level: LLTClassification code 10001130Term: Addison's diseaseADDISON'S DISEASEEUCTR2007-005170-30-FRCHU CAE
尚未招募
不适用
A randomised study to show the effect of hydrocortisone in outcome of patient with cardiac arrestCTRI/2021/02/031130Department of emergency medicine All India Institute of Medical Sciences New Delhi
已完成
不适用
Efficacy and safety of Hydrocortison-POS N1% and 2.5% versus Ficortril 0.5% in the treatment of acute inflammation of the ocular surface or adnexa for which steroid treatment is indicatedISRCTN15464650RSAPHARM Arzneimittel GmbH (Germany)411
